RAPT FY 2019 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$44M

Net Income

-$43M

EPS (Diluted)

$-15.75

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$36M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$85M

Total Liabilities

$11M

Stockholders' Equity

$73M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	-7.5%
Operating Income	-$44M	-$37M	-18.1%
Net Income	-$43M	-$36M	-19.0%